News
XRAY
30.57
+0.72%
0.22
Artisan Global Value Fund Q1 2024 Commentary
Artisan Global Value Fund Inv's top-performing stocks in the quarter were Meta, Heidelberg Materials and Progressive Insurance. Global markets notched a full year of gains in a quarter. Japan was the best performing major market, both in local currency and in dollars. Inflation has been a meaningful contributor to returns.
Seeking Alpha · 1d ago
Dentsply Sirona: I'm Buying The Pullback In This Medtech Leader
DENTSPLY SIRONA Inc. Is a leading supplier of dental products and supplies. The stock has recently pulled back to around $30 per share. The company manufactures and supplies everything from dental instruments to implants. Earnings estimates suggest a reasonable price to earnings ratio and the company has a low payout ratio for its dividend.
Seeking Alpha · 2d ago
Are Investors Undervaluing DENTSPLY SIRONA Inc. (NASDAQ:XRAY) By 47%?
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has a fair value estimate of US$57.90. Analyst price target for XRAY is US$36.47 which is 37% below the stock's actual value. We will use a discounted cash flow model to estimate the intrinsic value of the company. The company is valued at 47% below its current share price. The model is based on the discounted cash flows of the business over the next 10 years. DENTSPly Sirona's share price is currently 47% undervalued.
Simply Wall St · 4d ago
Weekly Report: what happened at XRAY last week (0415-0419)?
Weekly Report · 4d ago
A Glimpse Into The Expert Outlook On Dentsply Sirona Through 4 Analysts
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. The company has an average 12-month price target of $41.5. 4 analysts have published ratings on Dentsply sirona in the last three months. The average price target has increased by 1.22% over the past year.
Benzinga · 04/18 14:00
Dentsply Sirona Price Target Maintained With a $41.00/Share by Barrington Research
Dow Jones · 04/18 13:48
Dentsply Sirona Is Maintained at Outperform by Barrington Research
Dow Jones · 04/18 13:48
Barrington Research Maintains Outperform on Dentsply Sirona, Maintains $41 Price Target
Benzinga · 04/18 13:38
DENTSPLY SIRONA: Strong Growth and Efficiency Gains Signal Outperform Rating
TipRanks · 04/18 13:15
Dentsply Sirona Inc: Statement of changes in beneficial ownership of securities
Press release · 04/16 00:05
Weekly Report: what happened at XRAY last week (0408-0412)?
Weekly Report · 04/15 09:08
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
Needham sees BSX, CNMD, RMD and Surmodics beating Street, despite medtech slow down. Needham estimates medtech sales grew less than expected in Q1, but that Boston Scientific, CONMED and ResMed should still beat the Street. The investment firm says medtech market only grew by 5.3% in the first quarter of 2024.
Seeking Alpha · 04/14 21:56
Weekly Report: what happened at XRAY last week (0401-0405)?
Weekly Report · 04/08 09:08
Dividend Champion, Contender, And Challenger Highlights: Week Of April 7
The Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts. These dividend growth stocks have ex-dividend dates approaching. In the past week, the following companies declared dividends which changed from their previous payouts . Last chance to buy these stocks on the D dividend Champions list.
Seeking Alpha · 04/06 13:04
After Hours Most Active for Apr 2, 2024 : VFC, XRAY, FOXF, AAPL, T, CTSH, LYFT, AMZN, SOLV, BAC, BABA, GEV
NASDAQ · 04/02 20:24
DENTSPLY SIRONA (XRAY) Shares Cross 2% Yield Mark
NASDAQ · 04/01 19:07
DENTSPLY SIRONA (NASDAQ:XRAY) shareholders have endured a 46% loss from investing in the stock three years ago
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) shareholders have lost 48% in three years. The share price dropped 14% against a market return of 22% in the same period. In the last three years, the company has seen its revenue grow by 2.2% per year. The company has a total shareholder return of -46% for the last 3 years. We look at the company's fundamentals to see if the stock has matched the underlying business.
Simply Wall St · 04/01 11:42
Weekly Report: what happened at XRAY last week (0325-0329)?
Weekly Report · 04/01 09:08
Stocks Pressured by Hawkish Statement by a Fed Official
US stocks wavering today after strong-than-expected Q4 GDP report. Euro Stoxx 50 rises to a new 23-year high. Bond yields are higher after strong economic reports. Hawkish comments from Fed Governor Waller pushed bond yields higher. The S&P 500 and Dow Jones industrials are mixed.
Barchart · 03/28 10:32
Stocks See Support from Improved Soft-Landing Prospects
US stock indexes are slightly higher this morning. Euro Stoxx 50 rose to a 23-year high. Q4 GDP report revised higher and weekly jobless claims unexpectedly declined. Fed Governor Waller said there's no rush for the Fed to ease monetary policy. European stock markets mixed.
Barchart · 03/28 09:24
More
Webull provides a variety of real-time XRAY stock news. You can receive the latest news about Dentsply Sirona Inc through multiple platforms. This information may help you make smarter investment decisions.
About XRAY
DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. It develops, manufactures, and markets a comprehensive solution offering including dental and oral health products as well as other consumable medical devices. Its Connected Technology Solutions segment includes the design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of its value-added endodontic, restorative, and preventive consumable products and small equipment used in dental offices for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and dental professional directed aligner solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for both urinary and bowel management.